Computational analysis of complement inhibitor compstatin using molecular dynamics.

Area of Science:

• Immunology
• Computational Biology
• Biochemistry

Background:

• The complement system is crucial for immunity but its dysregulation causes disease.
• Compstatin is a peptide inhibitor of the complement system, with analogs showing improved potency.
• A new compstatin analog is a potential therapeutic for conditions like COVID-19, but its mechanism is unclear.

Purpose of the Study:

• To elucidate the mechanistic properties of compstatin analogs using computational methods.
• To understand the basis for increased potency and binding affinity in compstatin analogs.
• To complement existing experimental data on compstatin-mediated complement inhibition.

Main Methods:

• Molecular dynamics simulations of six compstatin analogs in solution.
• Simulations of two compstatin analogs complexed with complement component 3 (C3).
• Analysis of conformational preferences and binding interactions.

Main Results:

• Most compstatin analogs, unlike the original, adopt a pre-bound conformation in solution.
• This pre-bound conformation was observed in analogs not previously known to exhibit this behavior.
• The most recent analog demonstrated a more robust hydrogen bond network with its C3 receptor compared to an earlier analog.

Conclusions:

• The pre-bound conformation adopted by compstatin analogs contributes to their enhanced inhibitory function.
• Structural insights from this study can guide the development of more effective complement inhibitors.
• Understanding these mechanisms is vital for developing targeted therapies for complement-mediated diseases.